Search research articles
Contact Us
Filters
Showing results (1-10 of 96) with videos related to
Page
of 10
Sort By:
Bioorganic Chemistry
|
November 15, 2025
Recent advances in radionuclide drug conjugates (RDCs) for cancer theranostics: From targeted design to clinical translation
Liu Xijing, Binbin Cheng
Frontiers in Pharmacology
|
February 3, 2023
Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine
Man Yao, Shufang Liang, Binbin Cheng
European Journal of Medicinal Chemistry
|
July 15, 2025
Rational design of NAMPT-based dual inhibitors with improved drug-like and pharmacokinetic properties for cancer treatment
Jinke Lv, Binbin Cheng, Changshan Song
European Journal of Medicinal Chemistry
|
February 3, 2026
Discovery of potent bifunctional small molecules targeting DNA-PK and HDAC6 with desirable pharmacokinetic properties for acute myeloid leukemia treatment
Zongbao Ding, Xiaoqing Zhao, Binbin Cheng, et al.
European Journal of Medicinal Chemistry
|
August 2, 2024
Overview of class I HDAC modulators: Inhibitors and degraders
Ziqian Huang, Limei Zeng, Binbin Cheng, et al.
Frontiers in Oncology
|
December 6, 2021
The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment
Wentao Jia, Shufang Liang, Binbin Cheng, et al.
European Journal of Medicinal Chemistry
|
May 11, 2020
Discovery of novel resorcinol diphenyl ether-based PROTAC-like molecules as dual inhibitors and degraders of PD-L1
Binbin Cheng, Yichang Ren, Hao Cao, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 14, 2011
Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects
Juan Du, Binbin Cheng, Xiaoyan Zhu, et al.
Biochemical Pharmacology
|
March 20, 2021
Synthesis and pharmacological evaluation of novel resorcinol biphenyl ether analogs as small molecule inhibitors of PD-1/PD-L1 with benign toxicity profiles for cancer treatment
Hao Cao, Binbin Cheng, Ting Liu, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer
|
November 9, 2023
The role of dysregulated mRNA translation machinery in cancer pathogenesis and therapeutic value of ribosome-inactivating proteins
Wentao Jia, Jiaying Yuan, Shu Li, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 96) with videos related to
Sort By:
Page
of 10
Bioorganic Chemistry
|
November 15, 2025
Recent advances in radionuclide drug conjugates (RDCs) for cancer theranostics: From targeted design to clinical translation
Liu Xijing, Binbin Cheng
Frontiers in Pharmacology
|
February 3, 2023
Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine
Man Yao, Shufang Liang, Binbin Cheng
European Journal of Medicinal Chemistry
|
July 15, 2025
Rational design of NAMPT-based dual inhibitors with improved drug-like and pharmacokinetic properties for cancer treatment
Jinke Lv, Binbin Cheng, Changshan Song
European Journal of Medicinal Chemistry
|
February 3, 2026
Discovery of potent bifunctional small molecules targeting DNA-PK and HDAC6 with desirable pharmacokinetic properties for acute myeloid leukemia treatment
Zongbao Ding, Xiaoqing Zhao, Binbin Cheng, et al.
European Journal of Medicinal Chemistry
|
August 2, 2024
Overview of class I HDAC modulators: Inhibitors and degraders
Ziqian Huang, Limei Zeng, Binbin Cheng, et al.
Frontiers in Oncology
|
December 6, 2021
The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment
Wentao Jia, Shufang Liang, Binbin Cheng, et al.
European Journal of Medicinal Chemistry
|
May 11, 2020
Discovery of novel resorcinol diphenyl ether-based PROTAC-like molecules as dual inhibitors and degraders of PD-L1
Binbin Cheng, Yichang Ren, Hao Cao, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 14, 2011
Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects
Juan Du, Binbin Cheng, Xiaoyan Zhu, et al.
Biochemical Pharmacology
|
March 20, 2021
Synthesis and pharmacological evaluation of novel resorcinol biphenyl ether analogs as small molecule inhibitors of PD-1/PD-L1 with benign toxicity profiles for cancer treatment
Hao Cao, Binbin Cheng, Ting Liu, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer
|
November 9, 2023
The role of dysregulated mRNA translation machinery in cancer pathogenesis and therapeutic value of ribosome-inactivating proteins
Wentao Jia, Jiaying Yuan, Shu Li, et al.
Page
of 10